Literature DB >> 171445

Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus.

D M Hunt, R R Wagner.   

Abstract

The in vitro activity of the ribonucleoprotein-dependent RNA transcriptase of vesicular stomatitis virions was found to be completely inhibited by low concentrations of aurintricarboxylic acid (ATA) and polyethylene sulfonic acid (PES) when these inhibitors were added before the start of the RNA polymerase reaction. However, if RNA synthesis was allowed to occur before ATA or PES was added, RNA synthesis continued for a short time (10 min or less) in the presence of either inhibitor at a concentration which completely inhibited uninitiated enzyme. The ability to continue to synthesize RNA in the presence of ATA or PES only developed if all four nucleoside triphosphates were present during the preincubation period prior to the addition of the inhibitors. The protection was apparently not due to the released products of RNA polymerization. The results are interpreted as indicating that ATA and PES probably inhibit some reaction other than elongation of RNA chains, and this reaction might be one involved at or near initiation sites.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171445      PMCID: PMC355713     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  The interaction of aurintricarboxylic acid with ribosomal proteins and its application to gel electrophoresis.

Authors:  T Hultin; H Nika
Journal:  FEBS Lett       Date:  1975-03-01       Impact factor: 4.124

2.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

3.  Translation of individual species of vesicular stomatitis viral mRNA.

Authors:  D Knipe; J K Rose; H F Lodish
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

4.  Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  G W Both; S A Moyer; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

5.  Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells.

Authors:  G W Both; S A Moyer; A K Banerjee
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules.

Authors:  A S Huang; D Baltimore; M Stampfer
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells.

Authors:  J A Mudd; D F Summers
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.

Authors:  D Baltimore; A S Huang; M Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

10.  Inhibition of RNA polymerase by sodium polyethylene sulphonate.

Authors:  P Chambon; M Ramuz; P Mandel; J Doly
Journal:  Biochim Biophys Acta       Date:  1967-12-19
View more
  10 in total

1.  Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.

Authors:  Krzysztof Pyrc; Berend Jan Bosch; Ben Berkhout; Maarten F Jebbink; Ronald Dijkman; Peter Rottier; Lia van der Hoek
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

3.  Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.

Authors:  Chad Myskiw; Yvon Deschambault; Kristel Jefferies; Runtao He; Jingxin Cao
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Mass and molecular composition of vesicular stomatitis virus: a scanning transmission electron microscopy analysis.

Authors:  D Thomas; W W Newcomb; J C Brown; J S Wall; J F Hainfeld; B L Trus; A C Steven
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.

Authors:  Anwar M Hashem; Anathea S Flaman; Aaron Farnsworth; Earl G Brown; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

6.  In vitro reassembly of vesicular stomatitis virus skeletons.

Authors:  W W Newcomb; G J Tobin; J J McGowan; J C Brown
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

7.  Vesicular stomatitis virus mutant with altered polyadenylic acid polymerase activity in vitro.

Authors:  D M Hunt
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

8.  Effect of sulfhydryl reagents on the infectivity of vesicular stomatitis virus.

Authors:  S T Beatrice; R R Wagner
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

9.  Asymmetric distribution of phosphatidylethanolamine in the membrane of vesicular stomatitis virus.

Authors:  B S Fong; R C Hunt; J C Brown
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

10.  Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions.

Authors:  W W Newcomb; J C Brown
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.